natgillin/translations-raw huggingface dataset:
60 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
65 PODATKI NA ZUNANJI OVOJNINI
OUTER CARTON TEXT (BLISTER)
TEKST NA ŠKATLI (PRETISNI OMOT)
Lactose and colorants (E171, E172)
Laktoza in barvila (E171, E172)
62 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
67 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
BLISTER TEXT
TEKST NA PRETISNEM OMOTU
OTHERS
DRUGI PODATKI
63 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
68 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
OUTER CARTON TEXT AND BOTTLE LABEL TEXT (BOTTLE PRESENTATION)
TEKST NA ŠKATLI IN NALEPKI ZA PLASTENKO (PAKIRANJE V PLASTENKI)
65 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
70 PODATKI NA ZUNANJI OVOJNINI
67 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
72 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
68 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
73 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
70 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
75 PODATKI NA ZUNANJI OVOJNINI
72 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
77 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
73 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
78 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
75 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
80 PODATKI NA ZUNANJI OVOJNINI
77 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
82 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
78 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
83 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
80 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING OUTER CARTON TEXT AND BOTTLE LABEL TEXT
85 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Stavudine 200 mg The reconstituted solution contains 1 mg of stavudine per ml.
Stavudin 200 mg Pripravljena raztopina vsebuje 1 mg stavudina na ml.
Powder for oral solution, 200 mg (stavudine)
Prašek za peroralno raztopino, 200 mg (stavudin)
Stable for 30 days after reconstitution, when stored in a refrigerator (2°C-8°C).
Raztopina je stabilna 30 dni po pripravi, če se jo shranjujte v hladilniku (2°C - 8°C).
Before you take Zerit 3.
Kaj morate vedeti, preden boste vzeli zdravilo Zerit 3.
How to take Zerit 4.
Kako jemati zdravilo Zerit 4.
How to store Zerit 6.
Shranjevanje zdravila Zerit 6.
WHAT Zerit IS AND WHAT IT IS USED FOR
KAJ JE ZDRAVILO Zerit IN ZA KAJ GA UPORABLJAMO
Zerit belongs to a group of antiviral medicines, also known as antiretrovirals, called nucleoside reverse transcriptase inhibitors (NRTIs).
Zdravilo Zerit spada v skupino protivirusnih zdravil, znanih tudi kot protiretrovirusna zdravila, ki jih imenujemo nukleozidni in nukleotidni zaviralci reverzne transkriptaze (NRTIs, “ nucleoside reverse transcriptase inhibitors ”).
Treatment with Zerit has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer.
Ni dokazano, da bi zdravljenje z zdravilom Zerit zmanjševalo tveganje za prenos okužbe s HIV na druge s spolnimi stiki ali s krvjo.
Therefore, you must continue to take appropriate precautions to avoid giving the virus to others.
Zato morate še naprej upoštevati ustrezne previdnostne ukrepe, da ne boste virusa prenesli na druge.
During your treatment, other infections linked to your weakened immunity (opportunistic infections) may arise.
Med zdravljenjem se lahko pojavijo druge okužbe (oportunistične okužbe), povezane z oslabelo imunostjo.
BEFORE YOU TAKE Zerit
KAJ MORATE VEDETI, PREDEN BOSTE VZELI ZDRAVILO Zerit
If you are allergic (hypersensitive) to stavudine or any of the other ingredients of Zerit.
Ne jemljite zdravila Zerit Če ste alergični na (preobčutljivi za) stavudin ali katero koli sestavino zdravila Zerit.
Before treatment with Zerit, you should have told your doctor: if you suffer from kidney disease or liver disease (such as hepatitis), if you have had peripheral neuropathy (persistent numbness, tingling, or pain in the feet and/ or hands), or if you have suffered from pancreatitis (inflammation of the pancreas).
Bodite posebno pozorni pri uporabi zdravila Zerit Pred začetkom zdravljenja z zdravilom Zerit morate zdravniku povedati: če imate bolezen ledvic ali jeter (npr. hepatitis), če ste kdaj imeli periferno nevropatijo (trdovratna odrevenelost, mravljinčenje ali bolečine v stopalih in/ ali dlaneh), ali če ste kdaj imeli pankreatitis (vnetje trebušne slinavke).
The class of medicines to which Zerit belongs (NRTIs) can cause a sometimes fatal condition called lactic acidosis, together with an enlarged liver.
89 Skupina zdravil, v katero spada tudi zdravilo Zerit (NRTIs), lahko povzroči včasih usodno stanje, imenovano laktacidoza, in hkratno povečanje jeter.
This condition usually does not occur until a few
Stanje se ponavadi pojavi šele nekaj mesecev po začetku zdravljenja.
In addition, rare cases of liver failure/ renal failure or fatal hepatitis have been reported.
Poleg tega so bili opisani redki primeri odpovedi jeter/ odpovedi ledvic in usodnega hepatitisa.
Patients with chronic hepatitis B or C and treated with antiretroviral agents are at increased risk for severe and potentially fatal liver adverse events and may require blood tests for control of liver function.
Pri teh bolnikih bo morda za nadzor delovanja jeter treba opravljati krvne preiskave.
If you develop one of the following, contact your doctor: persistent numbness, tingling or pain in feet and/ or hands (this may indicate the beginning of peripheral neuropathy, an adverse effect on the nerves), muscular weakness or abdominal pain, nausea or vomiting, or rapid deep breathing, drowsiness (which may indicate pancreatitis, liver disturbance such as hepatitis, or lactic acidosis).
Če se pri vas pojavi kar koli od navedenega, o tem obvestite svojega zdravnika: trdovratna omrtvelost, mravljinčenje ali bolečine v stopalih in/ ali dlaneh (to lahko naznanja začetek periferne nevropatije, neželenega učinka na živcih), mišična šibkost, ali bolečine v trebuhu, siljenje na bruhanje ali bruhanje, ali hitro globoko dihanje, zaspanost (ki lahko nakazuje pankreatitis, motnje jeter, npr. hepatitis, ali laktacidozo).
Redistribution, accumulation, or loss of body fat may occur in patients receiving antiretroviral therapy.
Pri bolnikih, ki dobivajo protiretrovirusna zdravila, se lahko pojavi prerazporeditev, kopičenje ali izguba telesnega maščevja.
Some NRTIs, such as stavudine, have been associated with a loss of body fat (lipoatrophy).
Nekatera zdravila iz skupine NRTIs, kot je stavudin so bili povezani z izgubo telesnega maščevja (lipoatrofija).
Contact your doctor if you notice changes in body fat.
Če opazite spremembe v telesnem maščevju, se posvetujte z zdravnikom.
Bone problems: some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
Težave s kostmi: pri nekaterih bolnikih, ki jemljejo kombinirano protiretrovirusno zdravljenje, se lahko pojavi bolezen kosti, imenovana osteonekroza (odmiranje kostnega tkiva zaradi nezadostne prekrvitve kosti).
Except for zidovudine, which interferes with the activity of stavudine, Zerit may be taken with many of the other medicines commonly used in patients with HIV infection.
Z izjemo zidovudina, ki ovira delovanje stavudina, se lahko zdravilo Zerit jemlje s številnimi drugimi zdravili, ki se pogosto uporabljajo pri bolnikih, okuženih z virusom HIV.
These include the protease inhibitors (such as nelfinavir) and NRTIs.
Med takšne spadajo zaviralci proteaz (npr. nelfinavir) in zdravila iz skupine NRTIs.
Please tell your doctor if you are taking doxorubicin or ribavirin as undesirable interactions may occur.
Obvestite svojega zdravnika, če jemljete doksorubicin ali ribavirin, saj se lahko pojavi neželeno medsebojno delovanje.
For maximum effect, Zerit should be taken on an empty stomach, and preferably at least one hour before a meal.
Jemanje zdravila Zerit skupaj s hrano in pijačo Da bo zdravilo Zerit najbolj učinkovito, ga morate vzeti na prazen želodec in po možnosti vsaj eno uro pred obrokom.
Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child.
90 Nosečnost in dojenje Nosečnost Če zanosite ali načrtujete zanositev, se morate s svojim zdravnikom posvetovati o možnih neželenih učinkih ter koristih in tveganjih protiretrovirusnega zdravljenja za vas in vašega otroka.
Lactic acidosis (sometimes fatal) has been reported in pregnant women who received stavudine in combination with other antiretroviral treatment.
Pri nosečnicah, ki so se zdravile s stavudinom v kombinaciji z drugimi protiretrovirusnimi zdravili, so poročali o pojavu laktacidoze (ki se je v posameznih primerih končala tudi smrtno).
If you have taken Zerit during your pregnancy, your doctor may request regular visits to monitor the development of your child.
Če ste zdravilo Zerit jemali med nosečnostjo, vas lahko vaš zdravnik naroča na redne preglede, da bo spremljal razvoj vašega otroka.
85 Breast-feeding Inform your doctor if you are breast-feeding.
Dojenje Zdravniku povejte, če dojite.
No studies on the effects on the ability to drive and use machines have been performed.
Vpliv na sposobnost upravljanja vozil in strojev Študije o vplivih na sposobnost vožnje in upravljanja s stroji niso bile izvedene.
These capsules contain lactose.
Pomembne informacije o nekaterih sestavinah zdravila Zerit Kapsule vsebujejo laktozo.
HOW TO TAKE Zerit
KAKO JEMATI ZDRAVILO Zerit
Always take Zerit exactly as your doctor has told you.
Pri jemanju zdravila Zerit natančno upoštevajte zdravnikova navodila.
For adults and children whose body weight is 30 kg or more, the usual starting dose is 30 or 40 mg given twice daily (with approximately 12 hours between each dose).
Običajni začetni odmerek za odrasle in otroke s telesno maso vsaj 30 kg je 30 ali 40 mg dvakrat na dan (s približno 12- urnim presledkom med odmerki).
Children older than 3 months, whose body weight is less than 30 kg, should receive 1 mg/ kg twice daily.
Otroci, ki so starejši od 3 mesecev, a tehtajo manj kot 30 kg, morajo dobiti 1 mg/ kg dvakrat na dan.
If you have problems swallowing capsules you should ask your doctor about the possibility of changing to the solution form of this medicine or you could carefully open the capsule and mix its contents with some food.
Lahko pa kapsulo tudi previdno odprete in njeno vsebino zmešate z nekaj hrane.
If you accidentally miss a dose, then simply take your normal dose when the next one is due.
Če ste pozabili vzeti zdravilo Zerit Če pomotoma izpustite odmerek, preprosto vzemite normalen odmerek, ko je naslednjič čas za zdravilo.
The decision to stop using Zerit should be discussed with your doctor.
Če ste prenehali jemati zdravilo Zerit O prenehanju jemanja zdravila Zerit se morate posvetovati s svojim zdravnikom.
Like all medicines, Zerit can cause side effects, although not everybody gets them.
91 Kot vsa zdravila ima lahko tudi zdravilo Zerit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
The most frequently reported side effects in adults taking Zerit in combination with other HIV medicinal products (lamivudine and efavirenz) were skin rash, headache, dizziness and peripheral
Najpogosteje opisani neželeni učinki pri odraslih, ki so zdravilo Zerit jemali v kombinaciji z drugimi zdravili proti HIV (z lamivudinom in efavirenzom), so bili izpuščaj na koži, glavobol, omotica in periferna nevropatija.
Serious but uncommon side effects are pancreatitis, liver disturbance or lactic acidosis.
Resni, vendar le občasni neželeni učinki so pankreatitis, moteno delovanje jeter in laktacidoza.
Other side effects have been reported: fatigue, nausea/ vomiting, diarrhoea, indigestion, abdominal pain, fat redistribution (including breast enlargement in women), breast enlargement in men, numbness or weakness of arms and legs, muscle aching.
Opisani so bili še drugi neželeni učinki: utrujenost, siljenje na bruhanje/ bruhanje, driska, slaba prebava, bolečine v trebuhu, prerazporeditev maščevja (vključno s povečanjem prsi pri ženskah), povečanje prsi pri moških, omrtvelost ali šibkost rok in nog, bolečine v mišicah.
Some patients in studies of adults taking Zerit in combination with other HIV drugs (lamivudine and efavirenz) experienced changes in mood or ability to think clearly.
Nekateri bolniki v raziskavah odraslih, ki so jemali zdravilo Zerit v kombinaciji z drugimi zdravili proti HIV (lamivudinom in efavirenzom), so doživeli spremembe razpoloženja in spremembe v zmožnosti za jasno razmišljanje.
These symptoms include anxiety, sleeping problems, depression, abnormal thinking, abnormal dreams.
Ti simptomi vključujejo anksioznost, težave s spanjem, depresijo, nenormalno mišljenje, nenormalne sanje.
Combination antiretroviral therapy may cause changes in body shape due to changes in fat distribution.
Kombinirano protiretrovirusno zdravljenje lahko spremeni telesno obliko, ker povzroči spremembe v razporeditvi maščevja.
These may include loss of fat from legs, arms and face, increased fat in the abdomen ("belly") and other internal organs, breast enlargement and fatty lumps on the back of the neck ("buffalo hump").
To lahko obsega izginotje maščobnega tkiva na nogah, rokah in obrazu ter kopičenje maščob v trebuhu in drugih notranjih organih, zvečanje prsi in maščobno gmoto na zadnjem delu vratu ("bivolja grba").
The cause and long-term health effects of these conditions are not known at this time.
Vzrok in dolgoročne zdravstvene posledice teh motenj trenutno niso znane.
Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipaemia (increased fats in the blood) and resistance to insulin.
Kombinirano protiretrovirusno zdravljenje lahko povzroči tudi zvišanje mlečne kisline in sladkorja v krvi, hiperlipidemijo (zvišanje maščob v krvi) in odpornost proti insulinu.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell you doctor or pharmacist.
Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
HOW TO STORE Zerit
SHRANJEVANJE ZDRAVILA Zerit
Do not use Zerit after the expiry date which is stated on the carton, the bottle label and/ or the blister after EXP.
Zdravila Zerit ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatlici, nalepki plastenke in/ ali pretisnem omotu poleg oznake "Uporabno do".
- -
- Zdravilna učinkovina je stavudin.
The active substance is stavudine The other ingredients of the powder contained in the hard capsule are: lactose (120 mg), magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
- Pomožne snovi praška v trdih kapsulah so: laktoza (120 mg), magnezijev stearat, mikrokristalna
-
celuloza in natrijev karboksimetilškrob.
The ingredients of the capsule shell are gelatine, iron oxide colorant (E172), silicon dioxide, sodium laurilsulphate and titanium dioxide colorant (E171).
- Sestavine ovojnice kapsule so: želatina, železov oksid kot barvilo (E172), silicijev dioksid,
-
- Oznake na ovojnici kapsule so natisnjene z užitnim črnim črnilom, ki vsebuje: šelak,
The capsule shells are marked using edible black printing ink containing shellac, propylene glycol, purified water, potassium hydroxide and iron oxide (E172).
propilenglikol, prečiščeno vodo, kalijev hidroksid in železov oksid (E172).
Zerit 15 mg hard capsules are red and yellow and marked with “ BMS 1964” on one side and “ 15” on the other side.
92 Zerit 15 mg trde kapsule so rdeče in rumene in imajo oznako “ BMS 1964 ” na eni strani in “ 15 ” na drugi strani.
87 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom
BRISTOL- MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH – Velika Britanija
BRISTOL-MYERS SQUIBB Champ “ Lachaud”, La Goualle F-19250 Meymac - France
BRISTOL- MYERS SQUIBB Champ “ Lachaud ”, La Goualle F- 19250 Meymac – Francija
Contrada Fontana del Ceraso 03012 Anagni (FR) - Italy
Contrada Fontana del Ceraso 03012 Anagni (FR) – Italija
España BRISTOL-MYERS SQUIBB, S. A.
93 España BRISTOL- MYERS SQUIBB, S. A.
This leaflet was last approved in {month year}.
{mesec leto}.
INFORMATION FOR THE USER
94 NAVODILO ZA UPORABO
The class of medicines to which Zerit belongs (NRTIs) can cause a sometimes fatal condition called lactic acidosis, together with an enlarged liver.
95 Skupina zdravil, v katero spada tudi zdravilo Zerit (NRTIs), lahko povzroči včasih usodno stanje, imenovano laktacidoza, in hkratno povečanje jeter.
Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child.
96 Nosečnost in dojenje Nosečnost Če zanosite ali načrtujete zanositev, se morate s svojim zdravnikom posvetovati o možnih neželenih učinkih ter koristih in tveganjih protiretrovirusnega zdravljenja za vas in vašega otroka.
91 Breast-feeding Inform your doctor if you are breast-feeding.
Dojenje Zdravniku povejte, če dojite.
Like all medicines, Zerit can cause side effects, although not everybody gets them.
97 Kot vsa zdravila ima lahko tudi zdravilo Zerit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
The active substance is stavudine The other ingredients of the powder contained in the hard capsule are: lactose (180 mg), magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
- Pomožne snovi praška v trdih kapsulah so: laktoza (180 mg), magnezijev stearat, mikrokristalna
Zerit 20 mg hard capsules are brown and marked with “ BMS 1965” on one side and “ 20” on the other side.
98 Zerit 20 mg trde kapsule so rjave in imajo oznako “ BMS 1965 ” na eni strani in “ 20 ” na drugi strani.
93 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom
BRISTOL- MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH – Velika Britanija
España BRISTOL-MYERS SQUIBB, S. A.
99 España BRISTOL- MYERS SQUIBB, S. A.
The class of medicines to which Zerit belongs (NRTIs) can cause a sometimes fatal condition called lactic acidosis, together with an enlarged liver.
101 Skupina zdravil, v katero spada tudi zdravilo Zerit (NRTIs), lahko povzroči včasih usodno stanje, imenovano laktacidoza, in hkratno povečanje jeter.
Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child.
102 Nosečnost in dojenje Nosečnost Če zanosite ali načrtujete zanositev, se morate s svojim zdravnikom posvetovati o možnih neželenih učinkih ter koristih in tveganjih protiretrovirusnega zdravljenja za vas in vašega otroka.
97 Breast-feeding Inform your doctor if you are breast-feeding.
Dojenje Zdravniku povejte, če dojite.
Like all medicines, Zerit can cause side effects, although not everybody gets them.
103 Kot vsa zdravila ima lahko tudi zdravilo Zerit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Zerit 30 mg hard capsules are light and dark orange and marked with “ BMS 1966” on one side and “ 30” on the other side.
104 Zerit 30 mg trde kapsule so svetlo in temno oranžne in imajo oznako “ BMS 1966 ” na eni strani in “ 30 ” na drugi strani.
99 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom
BRISTOL- MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH – Velika Britanija
España BRISTOL-MYERS SQUIBB, S. A.
105 España BRISTOL- MYERS SQUIBB, S. A.
This condition usually does not occur until a few
107 Skupina zdravil, v katero spada tudi zdravilo Zerit (NRTIs), lahko povzroči včasih usodno stanje, imenovano laktacidoza, in hkratno povečanje jeter.
102 months after onset of treatment.
Stanje se ponavadi pojavi šele nekaj mesecev po začetku zdravljenja.
Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child.
108 Nosečnost in dojenje Nosečnost Če zanosite ali načrtujete zanositev, se morate s svojim zdravnikom posvetovati o možnih neželenih učinkih ter koristih in tveganjih protiretrovirusnega zdravljenja za vas in vašega otroka.
103 Breast-feeding Inform your doctor if you are breast-feeding.
Dojenje Zdravniku povejte, če dojite.
Like all medicines, Zerit can cause side effects, although not everybody gets them.
109 Kot vsa zdravila ima lahko tudi zdravilo Zerit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
The active substance is stavudine The other ingredients of the powder contained in the hard capsule are: lactose (240 mg), magnesium stearate, microcrystalline cellulose and sodium starch glycolate.
- Pomožne snovi praška v trdih kapsulah so: laktoza (240 mg), magnezijev stearat, mikrokristalna
Zerit 40 mg hard capsules are dark orange and marked with “ BMS 1967” on one side and “ 40” on the other side.
110 Zerit 40 mg trde kapsule so temno oranžne in imajo oznako “ BMS 1967 ” na eni strani in “ 40 ” na drugi strani.
105 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom
BRISTOL- MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH – Velika Britanija
España BRISTOL-MYERS SQUIBB, S. A.
111 España BRISTOL- MYERS SQUIBB, S. A.
During your treatment, other infections, linked to your weakened immunity (opportunistic infections) may arise.
Med zdravljenjem se lahko pojavijo druge okužbe (oportunistične okužbe), povezane z oslabelo imunostjo.
This condition usually does not occur until a few
113 Skupina zdravil, v katero spada tudi zdravilo Zerit (NRTIs), lahko povzroči včasih usodno stanje, imenovano laktacidoza, in hkratno povečanje jeter.
108 months after onset of treatment.
Stanje se ponavadi pojavi šele nekaj mesecev po začetku zdravljenja.
Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child.
114 Nosečnost in dojenje Nosečnost Če zanosite ali načrtujete zanositev, se morate s svojim zdravnikom posvetovati o možnih neželenih učinkih ter koristih in tveganjih protiretrovirusnega zdravljenja za vas in vašega otroka.
Lactic acidosis (sometimes fatal) has been reported in pregnant women who received stavudine in combination with other antiretroviral treatment.
Pri nosečnicah, ki so se zdravile s stavudinom v kombinaciji z drugimi protiretrovirusnimi zdravili so poročali o pojavu laktacidoze (ki se je v posameznih primerih končala tudi smrtno).
109 Breast-feeding Inform your doctor if you are breast-feeding.
Dojenje Zdravniku povejte, če dojite.
This should be taken into account in patients with diabetes mellitus.
Pomembne informacije o nekaterih sestavinah zdravila Zerit Po pripravi z vodo vsebuje raztopina 50 mg saharoze na mililiter, kar je treba upoštevati pri bolnikih, ki imajo sladkorno bolezen.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Če veste da katerega od sladkorjev ne prenašate (intoleranca), o tem obvestite svojega zdravnika preden začnete jemati to zdravilo.
This product contains methylhydroxybenzoate (E218) and propylhydroxybenzoate (E216) that may cause allergic reactions (possibly delayed).
Zdravilo vsebuje metilparahidroksibenzoat (E218) in propilparahidroksibenzoat (E216), ki lahko povzročita alergijske reakcije (ki so lahko zakasnjene).
Babies from birth to 13 days old should receive 0.5 mg/ kg twice daily.
Dojenčki od rojstva do 13. dne starosti morajo dobivati 0, 5 mg/ kg dvakrat na dan.